Dapagliflozin

A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve

Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.

A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy

Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients

Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes

A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease

Anti-Diabetic Medications to Fight PD and LBD

SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes in Non-diabetic ACS Patients Without HF

The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease

Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

SGLT2 Inhibitors in Geographic Atrophy

Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study

Dapagliflozin in Depression